MCM9 Gene - Minichromosome Maintenance 9 Homologous Recombination Repair Factor
Essential for DNA repair, genome stability, and meiotic recombination
Gene Information Card
| Symbol | MCM9 |
|---|---|
| Full Name | Minichromosome Maintenance 9 Homologous Recombination Repair Factor |
| Gene Type | Protein-coding |
| Chromosomal Location | 6q22.31 |
| NCBI Gene ID | 254394 ncbi.nlm.nih.gov/gene/254394 |
| Ensembl ID | ENSG00000111877 |
| UniProt ID | Q9NXL9 |
| OMIM ID | 610098 |
| HGNC ID | 21484 |
| Aliases | MCM9, MCMDC2, MCM9_HUMAN |
Description
MCM9 (Minichromosome Maintenance 9) is a protein-coding gene that encodes a member of the minichromosome maintenance (MCM) protein family. Unlike canonical MCM proteins involved in DNA replication initiation, MCM9 functions primarily in DNA homologous recombination repair and maintenance of genome stability. It forms a complex with MCM8 that is essential for homologous recombination-mediated DNA double-strand break repair and meiotic recombination. MCM9 is also critical for replication fork stability and telomere maintenance. Loss-of-function mutations in MCM9 cause primary ovarian insufficiency and are associated with increased cancer risk.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Primary Ovarian Insufficiency 4 (POI4) | Biallelic loss-of-function mutations impair homologous recombination repair, leading to meiotic arrest and premature ovarian failure. | OMIM #618149; ClinVar |
| MCM9-related cancer predisposition | Defective DNA repair due to MCM9 mutations increases genomic instability, predisposing to various cancers including breast, ovarian, and colorectal. | COSMIC; ClinVar |
| Premature ovarian failure with genomic instability | MCM9 deficiency disrupts meiotic recombination and DNA repair, causing ovarian dysgenesis and chromosomal instability. | OMIM #610098; NCBI Gene |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.3 | Medium |
| Ovary | 8.7 | Medium |
| Bone marrow | 6.2 | Low |
| Lymph node | 5.1 | Low |
| Spleen | 4.8 | Low |
| Thymus | 4.5 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 15.2 | High expression in embryonic kidney cells |
| HeLa | 10.1 | Moderate expression in cervical cancer cells |
| K562 | 7.3 | Low expression in leukemia cells |
| HepG2 | 6.8 | Low expression in liver cancer cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1730C>T (p.Pro577Leu) | Missense | Rare | Loss of function; impairs MCM8-MCM9 complex formation |
| c.1486C>T (p.Arg496*) | Nonsense | Rare | Premature stop; complete loss of protein function |
| c.394C>T (p.Arg132*) | Nonsense | Rare | Loss of function; associated with primary ovarian insufficiency |
| c.1A>G (p.Met1?) | Start loss | Rare | No protein translation; severe phenotype |
Mutation functional classification
Loss of Function (LOF)
Most MCM9 mutations are loss-of-function, impairing homologous recombination repair and causing genomic instability. Biallelic loss leads to primary ovarian insufficiency and cancer predisposition.
Gain of Function (GOF)
No gain-of-function mutations reported in MCM9.
Dominant Negative (DN)
No dominant-negative mutations reported; MCM9-associated disorders are autosomal recessive.
View complete mutation data:
Gene Ontology (GO)
| • ATP binding (GO:0005524) | • DNA helicase activity (GO:0003678) |
| • DNA recombination (GO:0006310) | • DNA repair (GO:0006281) |
| • double-strand break repair via homologous recombination (GO:0000724) | • reciprocal meiotic recombination (GO:0007131) |
| • replication fork protection (GO:0048478) | • nucleus (GO:0005634) |
Pathways
• Homologous recombination repair (Reactome: R-HSA-5693568)
• Meiotic recombination (Reactome: R-HSA-1500620)
• DNA double-strand break repair (KEGG: hsa03440)
• Fanconi anemia pathway (KEGG: hsa03460)
Protein Summary
MCM9 is a 1143-amino acid protein (UniProt Q9NXL9) belonging to the MCM family of AAA+ ATPases. It contains an MCM N-terminal domain and a C-terminal winged-helix domain. MCM9 forms a stable complex with MCM8, which together function as a DNA helicase essential for homologous recombination repair. The MCM8-MCM9 complex promotes the extension of recombination intermediates and facilitates the repair of DNA double-strand breaks. MCM9 is also involved in replication fork stabilization and telomere maintenance. Its expression is highest in testis and ovary, consistent with its critical role in meiosis. Mutations in MCM9 cause primary ovarian insufficiency and increase susceptibility to various cancers.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MCM9 Knockout HEK293 Cell Line | EDJ-KQ11767 | Human | 254394 | Details Get a Quote |
| MCM9 Knockout A-549 Cell Line | EDJ-KQ40160 | Human | 254394 | Details Get a Quote |
| MCM9 Knockout HeLa Cell Line | EDJ-KQ40162 | Human | 254394 | Details Get a Quote |
| MCM9 Knockout HCT 116 Cell Line | EDJ-KQ38901 | Human | 254394 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records